← Back to all trials
Completed
NCT00001254
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Conditions: Zollinger Ellison Syndrome
Sex: All
Ages: 18 Years – 100 Years
Healthy volunteers: No
Enrollment: 273
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Location: National Institutes of Health Clinical Center Bethesda Maryland
Summary
This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.
Eligibility Criteria
* INCLUSION CRITERIA:
New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005).
Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.
Source: ClinicalTrials.gov (NCT00001254). StuddyBuddy aggregates publicly available trial information.
